The ANKRD22 is reported to promote non-small cell lung cancer (Yin et al., 2017), and STAMBPL1 is oncogenic in gastric cancer (Yu et al., 2019). The gene discussed is STAMBPL1; the disease is non-small cell lung carcinoma.